Charles A. III Reinhart
CIK 1470871 · Chief Financial Officer · last filed 2024-06-13
Charles A. III Reinhart is a Chief Financial Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for PCRX, was dated Jun 13, 2024. Across all open-market trades the lifetime net is −$556.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.19M
2
17
-$556.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Chief Financial Officer | 51,867 | $22.99 | $1.19M | -$556.0K | 15 | 2024-06-13 |
| Altimmune, Inc. (PIP) Delisted | SVP, Chief Financial Officer | — | — | — | $0 | 2 | 2010-12-10 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-13 | PCRX | Grant (A) | +12,220 | $0 | EDGAR |
| 2024-06-05 | PCRX | Tax (F) | −2,979 | -$92.0K | EDGAR |
| 2023-06-16 | PCRX | Grant (A) | +9,000 | $0 | EDGAR |
| 2023-06-07 | PCRX | Sell (S) | −2,607 | -$100.1K | EDGAR |
| 2022-06-08 | PCRX | Mixed | +5,434 | -$154.4K | EDGAR |
| 2021-06-11 | PCRX | Grant (A) | +6,000 | $0 | EDGAR |
| 2021-06-08 | PCRX | Sell (S) | −2,648 | -$161.6K | EDGAR |
| 2020-06-11 | PCRX | Grant (A) | +12,600 | $0 | EDGAR |
| 2020-06-08 | PCRX | Sell (S) | −1,489 | -$69.0K | EDGAR |
| 2019-06-06 | PCRX | Mixed | +3,294 | -$47.5K | EDGAR |